• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重脓毒症患者治疗和诊断工具的有效性和死亡率的降低:一项长达 12 年的基于人群的队列研究。

Effectiveness of Treatments and Diagnostic Tools and Declining Mortality in Patients With Severe Sepsis: A 12-Year Population-Based Cohort Study.

机构信息

Department of Emergency Medicine, 125573Chang Gung Memorial Hospital, Keelung.

Department of Emergency Medicine, 125573Chang Gung Memorial Hospital, Linkou.

出版信息

J Intensive Care Med. 2020 Dec;35(12):1418-1425. doi: 10.1177/0885066619827270. Epub 2019 Jan 30.

DOI:10.1177/0885066619827270
PMID:30700200
Abstract

Sepsis is a major cause of morbidity and mortality worldwide. With the advance of medical care, the mortality of sepsis has decreased in the past decades. Many treatments and diagnostic tools still lack supporting evidence. We conducted a retrospective population-based cohort study with propensity score matched subcohorts based on a prospectively collected national longitudinal health insurance database in Taiwan. Severe sepsis-associated hospital admissions from 2000 to 2011 based on codes of infections and acute organ dysfunction were identified. To compare the effectiveness of treatment and diagnostic tool, propensity scores were generated to match the comparable control groups. During the 12-year period, 33 375 patients and 50 465 hospitalizations of severe sepsis were identified. The age-standardized 28-day in-hospital mortality decreased significantly from 21% in 2008 to 15% in 2011 with increasingly implemented treatment and diagnostic tool. After propensity score matching, procalcitonin (odds ratio [OR]: 0.70, 95% confidence interval [95% CI]: 0.61-0.81) and lactate testing (OR: 0.90, 95% CI: 0.84-0.97, respectively), transfusion of packed red blood cell (OR: 0.60, 95% CI: 0.52-0.69), albumin (OR: 0.72, 95% CI: 0.55-0.93), balanced crystalloid (OR: 0.29, 95% CI: 0.20-0.41), and use of dopamine (OR: 0.44, 95% CI: 0.39-0.49) were found to be significantly associated with lower mortality rate. However, inconsistent findings need to be further validated.

摘要

脓毒症是全球发病率和死亡率的主要原因。随着医疗水平的提高,过去几十年脓毒症的死亡率有所下降。许多治疗方法和诊断工具仍然缺乏支持证据。我们在台湾进行了一项基于前瞻性收集的全国纵向医疗保险数据库的回顾性基于人群的队列研究,并进行了倾向评分匹配的亚组分析。根据感染和急性器官功能障碍的代码确定了 2000 年至 2011 年严重脓毒症相关的医院入院情况。为了比较治疗和诊断工具的效果,我们生成了倾向评分以匹配可比的对照组。在 12 年期间,确定了 33375 名患者和 50465 例严重脓毒症的住院治疗。2008 年标准化 28 天院内死亡率为 21%,2011 年降至 15%,这与越来越多的治疗和诊断工具的应用有关。经过倾向评分匹配后,降钙素原(比值比 [OR]:0.70,95%置信区间 [95%CI]:0.61-0.81)和乳酸检测(OR:0.90,95%CI:0.84-0.97)、输注浓缩红细胞(OR:0.60,95%CI:0.52-0.69)、白蛋白(OR:0.72,95%CI:0.55-0.93)、平衡晶体(OR:0.29,95%CI:0.20-0.41)和使用多巴胺(OR:0.44,95%CI:0.39-0.49)与较低的死亡率显著相关。然而,需要进一步验证不一致的发现。

相似文献

1
Effectiveness of Treatments and Diagnostic Tools and Declining Mortality in Patients With Severe Sepsis: A 12-Year Population-Based Cohort Study.严重脓毒症患者治疗和诊断工具的有效性和死亡率的降低:一项长达 12 年的基于人群的队列研究。
J Intensive Care Med. 2020 Dec;35(12):1418-1425. doi: 10.1177/0885066619827270. Epub 2019 Jan 30.
2
Preadmission Use of Calcium Channel Blocking Agents Is Associated With Improved Outcomes in Patients With Sepsis: A Population-Based Propensity Score-Matched Cohort Study.入院前使用钙通道阻滞剂与脓毒症患者预后改善相关:一项基于人群的倾向评分匹配队列研究。
Crit Care Med. 2017 Sep;45(9):1500-1508. doi: 10.1097/CCM.0000000000002550.
3
STROBE-compliant article: Blood Transfusions within the First 24 Hours of Hospitalization Did Not Impact Mortality Among Patients with Severe Sepsis.符合STROBE标准的文章:住院后24小时内输血对严重脓毒症患者的死亡率无影响。
Medicine (Baltimore). 2016 Jan;95(4):e2601. doi: 10.1097/MD.0000000000002601.
4
Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*.严重脓毒症患者晶体液选择与院内死亡率的关系*。
Crit Care Med. 2014 Jul;42(7):1585-91. doi: 10.1097/CCM.0000000000000305.
5
Severe sepsis in hematopoietic stem cell transplant recipients*.造血干细胞移植受者中的严重脓毒症*。
Crit Care Med. 2015 Feb;43(2):411-21. doi: 10.1097/CCM.0000000000000714.
6
Preadmission Antihypertensive Drug Use and Sepsis Outcome: Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs).入院前使用抗高血压药物与脓毒症结局:血管紧张素转换酶抑制剂(ACEI)和血管紧张素受体阻滞剂(ARB)的影响。
Shock. 2020 Apr;53(4):407-415. doi: 10.1097/SHK.0000000000001382.
7
Sepsis outcomes in solid organ transplant recipients.实体器官移植受者的脓毒症结局
Transpl Infect Dis. 2020 Feb;22(1):e13214. doi: 10.1111/tid.13214. Epub 2019 Dec 2.
8
Case Fatality and Adverse Outcomes Are Reduced in Pregnant Women With Severe Sepsis or Septic Shock Compared With Age-Matched Comorbid-Matched Nonpregnant Women.与年龄匹配的合并症非孕妇相比,患有严重脓毒症或脓毒性休克的孕妇的病死率和不良结局降低。
Crit Care Med. 2018 Nov;46(11):1775-1782. doi: 10.1097/CCM.0000000000003348.
9
Crystalloid Fluid Choice and Clinical Outcomes in Pediatric Sepsis: A Matched Retrospective Cohort Study.小儿脓毒症中晶体液的选择与临床结局:一项配对回顾性队列研究
J Pediatr. 2017 Mar;182:304-310.e10. doi: 10.1016/j.jpeds.2016.11.075. Epub 2017 Jan 4.
10
Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014.2009 - 2014年美国医院中使用临床数据与索赔数据的脓毒症发病率及趋势
JAMA. 2017 Oct 3;318(13):1241-1249. doi: 10.1001/jama.2017.13836.

引用本文的文献

1
Using Machine Learning to Develop and Validate an In-Hospital Mortality Prediction Model for Patients with Suspected Sepsis.利用机器学习开发并验证疑似脓毒症患者的院内死亡率预测模型。
Biomedicines. 2022 Mar 29;10(4):802. doi: 10.3390/biomedicines10040802.
2
Current Evidence and Limitation of Biomarkers for Detecting Sepsis and Systemic Infection.检测脓毒症和全身感染生物标志物的当前证据及局限性
Biomedicines. 2020 Nov 12;8(11):494. doi: 10.3390/biomedicines8110494.
3
Stroke Rate Increases Around the Time of Cancer Diagnosis.癌症诊断前后中风发生率增加。
Front Neurol. 2019 Jun 7;10:579. doi: 10.3389/fneur.2019.00579. eCollection 2019.